3 studies found for:    ((AT13387 AND GIST) OR NCT01245218 OR NCT00878423)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Condition: Metastatic Solid Tumors
Intervention: Drug: AT13387
2 Active, not recruiting A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: AT13387 and Imatinib
3 Completed AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer
Intervention: Drug: AT13387

Indicates status has not been verified in more than two years